文献
J-GLOBAL ID:201802264510998441
整理番号:18A0085548
抗マイコバクテリア活性のための新しい置換イサチンプロピレン-1H-1,2,3-triazole-4-メチレンモキシフロキサシンハイブリッドの合成とin vitro評価【Powered by NICT】
Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities
著者 (5件):
Yan Xinjia
(College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang Province 150076, PR China)
,
Lv Zaosheng
(Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Hubei, PR China)
,
Wen Jing
(College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang Province 150076, PR China)
,
Zhao Shijia
(DXC PharmaTech (Hubei) Co. Ltd., Hubei, PR China)
,
Xu Zhi
(Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Hubei, PR China)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
143
ページ:
899-904
発行年:
2018年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)